These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12176220)

  • 1. Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution.
    Chen X; Young TJ; Sarkari M; Williams RO; Johnston KP
    Int J Pharm; 2002 Aug; 242(1-2):3-14. PubMed ID: 12176220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced drug dissolution using evaporative precipitation into aqueous solution.
    Sarkari M; Brown J; Chen X; Swinnea S; Williams RO; Johnston KP
    Int J Pharm; 2002 Aug; 243(1-2):17-31. PubMed ID: 12176292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity.
    Guada M; Sebastián V; Irusta S; Feijoó E; Dios-Viéitez Mdel C; Blanco-Prieto MJ
    Int J Nanomedicine; 2015; 10():6541-53. PubMed ID: 26527872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilizer choice for rapid dissolving high potency itraconazole particles formed by evaporative precipitation into aqueous solution.
    Sinswat P; Gao X; Yacaman MJ; Williams RO; Johnston KP
    Int J Pharm; 2005 Sep; 302(1-2):113-24. PubMed ID: 16109466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release.
    Hu FQ; Wu MZh; Yuan H; Zhang HH
    Pharmazie; 2004 Sep; 59(9):683-5. PubMed ID: 15497749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryogenic liquids, nanoparticles, and microencapsulation.
    Purvis T; Vaughn JM; Rogers TL; Chen X; Overhoff KA; Sinswat P; Hu J; McConville JT; Johnston KP; Williams RO
    Int J Pharm; 2006 Oct; 324(1):43-50. PubMed ID: 16814968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid-stabilized nanoparticles of cyclosporine A by rapid expansion from supercritical to aqueous solution.
    Young TJ; Johnson KP; Pace GW; Mishra AK
    AAPS PharmSciTech; 2004 Feb; 5(1):E11. PubMed ID: 15198532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology of stable, prolonged-release eye-drops containing Cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM).
    Wolska E; Sznitowska M
    Int J Pharm; 2013 Jan; 441(1-2):449-57. PubMed ID: 23164704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former.
    Yamasaki K; Kwok PC; Fukushige K; Prud'homme RK; Chan HK
    Int J Pharm; 2011 Nov; 420(1):34-42. PubMed ID: 21864662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supersaturation produces high bioavailability of amorphous danazol particles formed by evaporative precipitation into aqueous solution and spray freezing into liquid technologies.
    Vaughn JM; McConville JT; Crisp MT; Johnston KP; Williams RO
    Drug Dev Ind Pharm; 2006 Jun; 32(5):559-67. PubMed ID: 16720411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a new cyclosporine formulation based on poly(caprolactone) microspheres.
    Aberturas MR; Molpeceres J; Guzmán M; García F
    J Microencapsul; 2002; 19(1):61-72. PubMed ID: 11811760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology.
    Liu G; Zhang D; Jiao Y; Zheng D; Liu Y; Duan C; Jia L; Zhang Q; Lou H
    Int J Pharm; 2012 Jan; 422(1-2):516-22. PubMed ID: 22119965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization.
    Matteucci ME; Hotze MA; Johnston KP; Williams RO
    Langmuir; 2006 Oct; 22(21):8951-9. PubMed ID: 17014140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation.
    Dong Y; Ng WK; Shen S; Kim S; Tan RB
    Int J Pharm; 2009 Jun; 375(1-2):84-8. PubMed ID: 19481693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of formulation and processing variables on properties of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution.
    Bosselmann S; Nagao M; Chow KT; Williams RO
    AAPS PharmSciTech; 2012 Sep; 13(3):949-60. PubMed ID: 22752680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems.
    Sandri G; Bonferoni MC; Gökçe EH; Ferrari F; Rossi S; Patrini M; Caramella C
    J Microencapsul; 2010; 27(8):735-46. PubMed ID: 21034366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid dissolution of high-potency danazol particles produced by evaporative precipitation into aqueous solution.
    Chen X; Vaughn JM; Yacaman MJ; Williams RO; Johnston KP
    J Pharm Sci; 2004 Jul; 93(7):1867-78. PubMed ID: 15176074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray-freezing into liquid with atmospheric freeze-drying.
    Rogers TL; Nelsen AC; Sarkari M; Young TJ; Johnston KP; Williams RO
    Pharm Res; 2003 Mar; 20(3):485-93. PubMed ID: 12669973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method.
    Wang Y; Han X; Wang J; Wang Y
    Int J Pharm; 2016 May; 505(1-2):35-41. PubMed ID: 27034003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.